Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (4) , 433-445
- https://doi.org/10.2165/00019053-199814040-00009
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Canadian Guidelines for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1996
- Selective Serotonin Reuptake InhibitorsPharmacoEconomics, 1996
- Cost Analysis of Paroxetine versus Imipramine in Major DepressionPharmacoEconomics, 1995
- ParoxetinePharmacoEconomics, 1995
- Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with DothiepinPharmacoEconomics, 1994
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Patterns of antidepressant use in community practiceGeneral Hospital Psychiatry, 1993
- Comorbid anxious signs and symptoms in major depressionInternational Clinical Psychopharmacology, 1993
- The costs of depressionInternational Clinical Psychopharmacology, 1993
- Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trialPsychological Medicine, 1984